• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prognostic significance of chromosome arm 1q gain and methylation class in molecularly defined diffuse leptomeningeal glioneuronal tumor.

作者信息

Chiang Jason, Moreira Daniel C, Li Xiaoyu, Furtado Larissa V

机构信息

Department of Pathology, St. Jude Children's Research Hospital, MS 250, Room C5024A, 262 Danny Thomas Place, Memphis, TN, 38105-3678, USA.

Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, 38105-3678, USA.

出版信息

Acta Neuropathol. 2022 Dec;144(6):1185-1187. doi: 10.1007/s00401-022-02507-3. Epub 2022 Sep 29.

DOI:10.1007/s00401-022-02507-3
PMID:36175668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9637611/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad7/9637611/221edb65ba13/401_2022_2507_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad7/9637611/221edb65ba13/401_2022_2507_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad7/9637611/221edb65ba13/401_2022_2507_Fig1_HTML.jpg

相似文献

1
Prognostic significance of chromosome arm 1q gain and methylation class in molecularly defined diffuse leptomeningeal glioneuronal tumor.1q染色体臂增加和甲基化类别在分子定义的弥漫性软脑膜神经胶质神经元肿瘤中的预后意义
Acta Neuropathol. 2022 Dec;144(6):1185-1187. doi: 10.1007/s00401-022-02507-3. Epub 2022 Sep 29.
2
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features.分子定义的弥漫性软脑膜神经胶质神经元肿瘤（DLGNT）包括两个具有不同临床和遗传特征的亚组。
Acta Neuropathol. 2018 Aug;136(2):239-253. doi: 10.1007/s00401-018-1865-4. Epub 2018 May 15.
3
A germline variant of TP53 in paediatric diffuse leptomeningeal glioneuronal tumour.小儿弥漫性软脑膜胶质神经元肿瘤中TP53的种系变异
Childs Nerv Syst. 2019 Jun;35(6):1021-1027. doi: 10.1007/s00381-019-04128-w. Epub 2019 Apr 2.
4
DNA methylation array analysis for diffuse leptomeningeal glioneuronal tumor with conspicuous hypothalamic mass. A case report.伴有明显下丘脑肿块的弥漫性软脑膜神经胶质瘤的DNA甲基化阵列分析。病例报告。
Neuropathology. 2022 Dec;42(6):512-518. doi: 10.1111/neup.12818. Epub 2022 Sep 7.
5
A Diffuse Leptomeningeal Glioneuronal Tumor Without Diffuse Leptomeningeal Involvement: Detailed Molecular and Clinical Characterization.无弥漫性软脑膜累及的弥漫性神经胶质神经元肿瘤：详细的分子和临床特征。
J Neuropathol Exp Neurol. 2018 Sep 1;77(9):751-756. doi: 10.1093/jnen/nly053.
6
Diffuse leptomeningeal glioneuronal tumours: clinico-pathological follow-up.弥漫性软脑膜神经胶质神经元肿瘤：临床病理随访
Pathologica. 2012 Dec;104(6):428-31.
7
Chromosome arm 1q gain is an adverse prognostic factor in localized and diffuse leptomeningeal glioneuronal tumors with BRAF gene fusion and 1p deletion.染色体臂1q增益是伴有BRAF基因融合和1p缺失的局限性和弥漫性软脑膜神经胶质瘤的不良预后因素。
Acta Neuropathol. 2019 Jan;137(1):179-181. doi: 10.1007/s00401-018-1940-x. Epub 2018 Nov 21.
8
Diffuse leptomeningeal glioneuronal tumor: a double misnomer? A report of two cases.弥漫性软脑膜胶质神经元肿瘤：双重错误命名？两例报告。
Acta Neuropathol Commun. 2020 Jun 30;8(1):95. doi: 10.1186/s40478-020-00978-7.
9
Adult diffuse leptomeningeal glioneuronal tumour with limited leptomeningeal involvement, lack of 1p deletion and BRAF V600E mutation.成人弥漫性软脑膜胶质神经元肿瘤，伴有限软脑膜累及，无 1p 缺失和 BRAF V600E 突变。
J Clin Neurosci. 2020 Sep;79:215-218. doi: 10.1016/j.jocn.2020.07.039. Epub 2020 Aug 6.
10
Prognostic factors in diffuse leptomeningeal glioneuronal tumor (DLGNT): a systematic review.弥漫性软脑膜胶质神经元肿瘤（DLGNT）的预后因素：系统评价。
Childs Nerv Syst. 2022 Sep;38(9):1663-1673. doi: 10.1007/s00381-022-05600-w. Epub 2022 Jul 22.

引用本文的文献

1
Diffuse leptomeningeal glioneuronal tumor (DLGNT): a comprehensive clinical and molecular analysis.弥漫性软脑膜胶质神经元肿瘤（DLGNT）：一项全面的临床与分子分析
Acta Neuropathol. 2025 Aug 11;150(1):18. doi: 10.1007/s00401-025-02924-0.
2
Improving global access to genomic profiling in rare pediatric cancers.改善全球范围内罕见儿科癌症的基因组分析可及性。
Clin Cancer Res. 2025 May 20. doi: 10.1158/1078-0432.CCR-24-3910.
3
Response to a novel type II RAF inhibitor in diffuse leptomeningeal glioneuronal tumor with BRAF fusion.BRAF融合的弥漫性软脑膜神经胶质瘤对新型II型RAF抑制剂的反应。

本文引用的文献

1
Chromosome arm 1q gain is an adverse prognostic factor in localized and diffuse leptomeningeal glioneuronal tumors with BRAF gene fusion and 1p deletion.染色体臂1q增益是伴有BRAF基因融合和1p缺失的局限性和弥漫性软脑膜神经胶质瘤的不良预后因素。
Acta Neuropathol. 2019 Jan;137(1):179-181. doi: 10.1007/s00401-018-1940-x. Epub 2018 Nov 21.
2
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features.分子定义的弥漫性软脑膜神经胶质神经元肿瘤（DLGNT）包括两个具有不同临床和遗传特征的亚组。
Acta Neuropathol. 2018 Aug;136(2):239-253. doi: 10.1007/s00401-018-1865-4. Epub 2018 May 15.
3
Oncologist. 2025 May 8;30(5). doi: 10.1093/oncolo/oyaf093.
4
Diffuse leptomeningeal glioneuronal tumor with distinct neuronal and glial components but identical diagnostic molecular and genetic features.弥漫性软脑膜神经胶质神经元肿瘤，具有明显的神经元和神经胶质成分，但具有相同的诊断分子和遗传特征。
Neuropathology. 2024 Dec;44(6):440-444. doi: 10.1111/neup.12996. Epub 2024 Jul 28.
5
Understanding diffuse leptomeningeal glioneuronal tumors.理解弥漫性软脑膜神经胶质神经元肿瘤。
Childs Nerv Syst. 2024 Aug;40(8):2359-2366. doi: 10.1007/s00381-024-06432-6. Epub 2024 May 25.
6
Diffuse Leptomeningeal Glioneuronal Tumor in Adults: Case Report and Literature Review.成人弥漫性软脑膜胶质神经元肿瘤：病例报告及文献综述
Case Rep Oncol. 2024 Feb 23;17(1):337-343. doi: 10.1159/000536400. eCollection 2024 Jan-Dec.
7
Whole Exome Sequencing of Thymoma Patients Exhibiting Exceptional Responses to Pemetrexed Monotherapy.对培美曲塞单药治疗有显著反应的胸腺瘤患者的全外显子组测序
Cancers (Basel). 2023 Aug 8;15(16):4018. doi: 10.3390/cancers15164018.
Low-grade spinal glioneuronal tumors with BRAF gene fusion and 1p deletion but without leptomeningeal dissemination.
伴有BRAF基因融合及1p缺失但无软脑膜播散的低度脊髓神经胶质神经元肿瘤
Acta Neuropathol. 2017 Jul;134(1):159-162. doi: 10.1007/s00401-017-1728-4. Epub 2017 May 25.